Vapotherm

About:

Vapotherm is a medical device company that develops a mask-free respiratory support tool.

Website: https://vapotherm.com

Twitter/X: Vapotherm

Top Investors: CIBC Innovation Banking, Perceptive Advisors, Crestline, Cross Creek, Adage Capital Management

Description:

Vapotherm is specializing in the development, manufacture, and marketing of respiratory devices that improve clinical outcomes, reduce overall delivery costs, and improve quality of life for patients. The company's breakthrough technology centers on the benefits of high flow delivery of breathing gases through a patented process for heating and humidification. Vapotherm high velocity therapy has been shown to provide proven, comfortable respiratory support without the use of a mask. High Velocity Therapy is a method of rethinking ventilatory support while keeping patient comfort and compliance in mind.

Total Funding Amount:

$277M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Exeter, New Hampshire, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)vtherm.com

Founders:

Bill Niland

Number of Employees:

251-500

Last Funding Date:

2023-02-08

IPO Status:

Public

Industries:

© 2025 bioDAO.ai